
Today's Most Important Downgrades
By Davit Kirakosyan Twilio (NYSE:TWLO) shares plunged 20% intra-day today after BofA Securities downgraded the company to Underperform from Buy and lowered its price target to $85.00 from...
By Davit Kirakosyan Twilio (NYSE:TWLO) shares plunged 20% intra-day today after BofA Securities downgraded the company to Underperform from Buy and lowered its price target to $85.00 from...
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about...
Shares of Catalent Inc. plunged 23.4% toward a record one-day selloff, and enough to pace the S&P 500's losers, after the contract drug manufacturing company reported fiscal first-quarter...
Shares of pharma, biotech as well as consumer healthcare products provider Catalent (NYSE:CTLT) are tanking today after the company posted lower-than-expected first-quarter numbers and...
Catalent (CTLT) reported Q1 EPS of $0.34, $0.24 worse than the analyst estimate of $0.58. Revenue for the quarter came in at $1.02 billion versus the consensus estimate of $1.08...
Catalent (NYSE:CTLT) reported Q4 EPS of $1.19, $0.05 better than the analyst estimate of $1.14. Revenue for the quarter came in at $1.31 billion versus the consensus estimate of $1.33...
Investing.com – U.S. equities were higher at the close on Tuesday, as gains in the Oil & Gas, Telecoms and Basic Materials sectors propelled shares higher. At the close in NYSE, the Dow...
Catalent (NYSE:CTLT) reported Q3 EPS of $1.04, $0.10 better than the analyst estimate of $0.94. Revenue for the quarter came in at $1.27 billion versus the consensus estimate of $1.22...
Pre-Open Stock Movers: Nkarta Inc (NASDAQ:NKTX) 90% HIGHER; announced positive preliminary Phase 1 data from independent dose finding studies of its two lead chimeric antigen receptor...
Investing.com – U.S. equities were lower at the close on Tuesday, as losses in the Healthcare, Financials and Technology sectors propelled shares lower. At the close in NYSE, the Dow Jones...
(Bloomberg) -- Biotech investor Dale Chappell was looking to start Humanigen Inc. with a clean slate when his hedge fund assumed control in 2016, but things took longer than expected. The...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.